期刊
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
卷 32, 期 3, 页码 347-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2012.06.005
关键词
Nitric oxide; Fractional concentration of exhaled NO; Asthma; Glucocorticoids
Nitric oxide (NO) is now considered an important biomarker for respiratory disease. Studies have confirmed that the fractional concentration of exhaled nitric oxide (FENO) is elevated in the airways of patients who have asthma in comparison with controls. The level of FENO correlates well with the presence and level of inflammation, and decreases with glucocorticoid treatment. NO has potential to be used not only as a diagnostic aid but also as a management tool for assessing severity, monitoring response to therapy, and gaining control of asthma symptoms. This article reviews the biology of NO and its role in respiratory disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据